The non-invasive detection of breast tumor in vivo and in situ was first investigated by FTIR fiber optics technique. The experiment result indicates that there are significant differences between the spectra of skin ...The non-invasive detection of breast tumor in vivo and in situ was first investigated by FTIR fiber optics technique. The experiment result indicates that there are significant differences between the spectra of skin outside breast tumor and normal breast tissues in the peak position and relative intensity. The in vivo FTIR spectroscopy can provide the information concerning whether the suspected tissue is cancerous or not. This recent result means that in situ FTIR spectroscopic method with fiber optics can be developed as a non-invasive, rapid and in vivo technique for early breast tumor detection.展开更多
目的探讨保留假体清创联合局部关节腔注射万古霉素治疗人工全膝关节置换术后早期感染的临床疗效和可行性。方法回顾性分析2015年1月至2018年2月,我院人工全膝关节置换术后感染应用保留假体清创联合局部万古霉素治疗的24例临床资料,其中...目的探讨保留假体清创联合局部关节腔注射万古霉素治疗人工全膝关节置换术后早期感染的临床疗效和可行性。方法回顾性分析2015年1月至2018年2月,我院人工全膝关节置换术后感染应用保留假体清创联合局部万古霉素治疗的24例临床资料,其中男性10例,女性14例;年龄56~79岁,平均(64.1±7.2)岁。外院感染22例,本院感染2例。病程12~28 d,平均(20.3±2.4)d。记录患者术前及末次随访的美国膝关节协会评分(knee society score,KSS)、美国特种外科医院(the hospital special surgery,HSS)膝关节评分、视觉模拟评分(visual analogue scale,VAS)、术后复发以及并发症情况,采用简易Likert量表法进行患者满意度评价。结果所有患者均获随访,随访时间8~41个月,平均(27.8±5.8)个月。手术成功率87.5%(21/24),术后并发症发生率16.7%(4/24)。本组病例术前KSS评分(52.3±9.8)分、HSS评分(54.7±10.3)分,末次随访分别为(83.4±18.0)分、(90.6±14.5)分,末次随访评分明显高于术前(P<0.05)。术前VAS评分为(6.3±1.8)分,末次随访降至(1.1±0.9)分,差异有统计学意义(P<0.05)。根据简易Liket量表,患者术后满意度为83.3%(20/24)。结论保留假体清创联合局部万古霉素治疗人工全膝关节术后早期感染是安全有效的,能够显著降低疼痛、提高膝关节功能,并有着较高的成功率及患者满意度,但远期疗效仍需进一步观察。展开更多
文摘The non-invasive detection of breast tumor in vivo and in situ was first investigated by FTIR fiber optics technique. The experiment result indicates that there are significant differences between the spectra of skin outside breast tumor and normal breast tissues in the peak position and relative intensity. The in vivo FTIR spectroscopy can provide the information concerning whether the suspected tissue is cancerous or not. This recent result means that in situ FTIR spectroscopic method with fiber optics can be developed as a non-invasive, rapid and in vivo technique for early breast tumor detection.
文摘目的探讨保留假体清创联合局部关节腔注射万古霉素治疗人工全膝关节置换术后早期感染的临床疗效和可行性。方法回顾性分析2015年1月至2018年2月,我院人工全膝关节置换术后感染应用保留假体清创联合局部万古霉素治疗的24例临床资料,其中男性10例,女性14例;年龄56~79岁,平均(64.1±7.2)岁。外院感染22例,本院感染2例。病程12~28 d,平均(20.3±2.4)d。记录患者术前及末次随访的美国膝关节协会评分(knee society score,KSS)、美国特种外科医院(the hospital special surgery,HSS)膝关节评分、视觉模拟评分(visual analogue scale,VAS)、术后复发以及并发症情况,采用简易Likert量表法进行患者满意度评价。结果所有患者均获随访,随访时间8~41个月,平均(27.8±5.8)个月。手术成功率87.5%(21/24),术后并发症发生率16.7%(4/24)。本组病例术前KSS评分(52.3±9.8)分、HSS评分(54.7±10.3)分,末次随访分别为(83.4±18.0)分、(90.6±14.5)分,末次随访评分明显高于术前(P<0.05)。术前VAS评分为(6.3±1.8)分,末次随访降至(1.1±0.9)分,差异有统计学意义(P<0.05)。根据简易Liket量表,患者术后满意度为83.3%(20/24)。结论保留假体清创联合局部万古霉素治疗人工全膝关节术后早期感染是安全有效的,能够显著降低疼痛、提高膝关节功能,并有着较高的成功率及患者满意度,但远期疗效仍需进一步观察。
